abferopharmaceuticals.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.abferopharmaceuticals.com/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | Abfero Pharmaceuticals | Iron as a Therapeutic |
| Description | Dedicated to treating diseases of iron Our mission is to develop best-in-class, safe and effective oral iron chelators for the treatment of diseases of iron |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 50.87.170.207 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
abferopharmaceuticals.com Valuation
|
US$2,325,946
Last updated: 2023-05-19 20:56:26
abferopharmaceuticals.com has Semrush global rank of 4,550,538. abferopharmaceuticals.com has an estimated worth of US$ 2,325,946, based on its estimated Ads revenue. abferopharmaceuticals.com receives approximately 268,379 unique visitors each day. Its web server is located in United States, with IP address 50.87.170.207. According to SiteAdvisor, abferopharmaceuticals.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,325,946 |
| Daily Ads Revenue | US$2,148 |
| Monthly Ads Revenue | US$64,411 |
| Yearly Ads Revenue | US$772,930 |
| Daily Unique Visitors | 17,892 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| abferopharmaceuticals.com. 14400 IN | A | IP: 50.87.170.207 | |
| abferopharmaceuticals.com. 21600 IN | NS | NS Record: ns2.bluehost.com. | |
| abferopharmaceuticals.com. 21600 IN | NS | NS Record: ns1.bluehost.com. | |
| abferopharmaceuticals.com. 14400 IN | MX | MX Record: 0 mail.abferopharmaceuticals.com. | |
| abferopharmaceuticals.com. 14400 IN | TXT | TXT Record: v=spf1 ip4:50.87.170.207 a mx include:websitewelcome.com include:bluehost.com ~all |
HtmlToTextCheckTime:2023-05-19 20:56:26
| Home The Science Our Technology Transfusional Iron Overload Iron and Age-Related Macular Degeneration Pipeline News Contact Select Page SP-420 Abfero Pharmaceuticals Dedicated to treating diseases of iron overload Our Technology info@AbFero.com AbFero Pharmaceuticals has been acquired by Pharmacosmos. More information > > SP-420 Our Lead CAndidate our mission Abfero Pharmaceuticals Inc. is a clinical stage pharmaceutical company focused exclusively on iron as a therapeutic target. Our mission is to develop best-in-class oral iron chelators for the treatment of diseases of iron overload. Patients with systemic iron overload due to transfusions or genetic conditions are at risk for severe organ damage and death. In addition, iron accumulation in the retina and brain are associated with a number of retinal and neurologic diseases leading to vision loss, neurodegeneration, and other debilitating conditions. Our lead, brain-penetrant small molecule SP-420 may prove an important |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Tue, 22 Nov 2022 08:21:26 GMT Server: Apache Location: https://abferopharmaceuticals.com/ Cache-Control: max-age=300 Expires: Tue, 22 Nov 2022 08:26:26 GMT Content-Type: text/html; charset=iso-8859-1 HTTP/2 301 x-redirect-by: WordPress location: https://www.abferopharmaceuticals.com/ cache-control: max-age=300 expires: Tue, 22 Nov 2022 08:26:27 GMT host-header: c2hhcmVkLmJsdWVob3N0LmNvbQ== x-endurance-cache-level: 2 content-type: text/html; charset=UTF-8 date: Tue, 22 Nov 2022 08:21:27 GMT server: Apache |
abferopharmaceuticals.com Whois Information
Domain Name: ABFEROPHARMACEUTICALS.COM Registry Domain ID: 2544319888_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.fastdomain.com Registrar URL: http://www.fastdomain.com Updated Date: 2022-06-30T13:58:53Z Creation Date: 2020-07-07T12:28:07Z Registry Expiry Date: 2023-07-07T12:28:07Z Registrar: FastDomain Inc. Registrar IANA ID: 1154 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.BLUEHOST.COM Name Server: NS2.BLUEHOST.COM DNSSEC: unsigned >>> Last update of whois database: 2022-11-22T08:19:03Z <<< |